Table 1.
Variable | Patient ID | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.1 | 1.2 | 1.3 | 1.4 | 2.1 | 2.2 | 3.1 | 4.1 | 5.1 | 6.1 | 7.1 | 8.1 | 9.1 | 9.2 | 10.1 | 10.2 | 11.1 | 12.1 | |
Sex | Male | Female | Female | Female | Female | Male | Male | Male | Female | Male | Female | Female | Male | Male | Female | Male | Female | Male |
Mutation | ||||||||||||||||||
Nucleotide | c.-167G>T/c.-167G>T | c.-167G>T/c.-167G>T | c.-167G>T/c.-167G>T | c.-167G>T/c.-167G>T | c.-167G>T/c.422G>A | c.-167G>T/c.422G>A | c.-167G>T/c.470T>C | c.-167G>T/c.422G>A | c.-167G>T/c.422G>A | c.-167G>T/c.422G>A | c.-167G>T/c.422G>A | c.-167G>T/c.255+1G>A | c.-167G>T/c.620T>C | c.-167G>T/c.620T>C | c.-167G>T/c.470T>C | c.-167G>T/c.470T>C | c.-167G>T/c.470T>C | c.-167G>T/c.24del |
Predicted protein | p.?/p.? | p.?/p.? | p.?/p.? | p.?/p.? | p.?/p.Arg141His | p.?/p.Arg141His | p.?/Phe157Ser | p.?/p.Arg141His | p.?/p.Arg141His | p.?/p.Arg141His | p.?/p.Arg141His | p.?/p.? | p.?/p.Phe207Ser | p.?/p.Phe207Ser | p.?/p.Phe157Ser | p.?/p.Phe157Ser | p.?/p.Phe157Ser | p.?/p.Leu8fsX |
Hyperinsulinism | ||||||||||||||||||
Birth weight, g | 2880 | 3400 | 3000 | 3750 | 3850 | 3400 | 3325 | 2960 | N/A | 4200 | 4252 | 4500 | 3440 | 3450 | N/A | 3720 | N/A | 3160 |
Age at diagnosis, mo | 6 | 10 | 48 | 10 | 0 | 8 | 21 | 0 | 4 | 0 | N/A | 12 | 14 | 0 | 18 | 11 | 14 | 24 |
Treatment | None | None | None | None | Diazoxide | Diazoxide | Diazoxide | Diazoxide | N/A | Diazoxide | Diazoxide/cornstarch | N/A | Diazoxide | Diazoxide | N/A | N/A | Diazoxide | Diazoxide |
Renal disease | ||||||||||||||||||
Antenatal abnormalities | Cysts/polyhydramnios | No | No | No | No | No | No | No | N/A | Cysts | N/A | N/A | Cysts | Cysts | N/A | N/A | No | No |
Age at renal diagnosis, mo | 0 | 6 | 48 | 11 | 48 | 0 | 21 | 0 | 36 | 0 | 36 | 15 | 0 | 0 | N/A | N/A | 20 | 0 |
eGFR at diagnosis, ml/min per 1.73 m2 | 70 | 100 | 85 | 115 | 95 | 90 | 90 | 50 | 95 | 20 | 120 | 75 | 30 | 40 | N/A | N/A | 105 | N/A |
Kidney size, percentile | >95th | >95th | >95th | >95th | >95th | >95th | >95th | >95th | >95th | >95th | >95th | >95th | N/A | N/A | N/A | N/A | >95th | >95th |
Morphology | Cysts | Hyperechogenicity/cysts | Hyperechogenicity/cysts | Hyperechogenicity/cysts | Cysts | Cysts | Cysts | Cysts | Cysts | Cysts | Cysts | Cysts | Cysts | Cysts | Cysts | Cysts | Cysts | Cysts |
Age at last f/u, yr | 10 | 15 | 20 | 14 | 11 | 4 | 1 | 2 | 14 | 6 | 11 | 7 | 4 | 0.3 | N/A | N/A | 11 | 19 |
eGFR at last f/u, ml/min per 1.73m2 | 70 | 90 | <10 (18) | 75 | 80 | 40 | 90 | 50 | 85 | <10 (2) | 141 | 40 | 65 | 70 | N/A | N/A | 94 | <10 (7) |
Liver disease | ||||||||||||||||||
Morphology (ultrasound) | Normal | Normal | Normal | Normal | Cysts | Cysts | Normal | Normal | Coarse echotexture | Cysts | Cysts | Normala | Normal | Normal | Cysts | N/A | Cysts | Cysts |
Liver function tests | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Normal | N/A | Normal | Normal | Normal | Normal | Normal | Normal | Normal | N/A | Normal |
Shown are pertinent clinical data for the 17 patients. Note the presence of the PMM2 promoter mutation c.-167G>T in all patients. ID, identifier; N/A, not available; f/u, follow-up.
Ultrasound imaging of the liver was normal, yet a biopsy revealed ductal plate malformation (see Figure 3).